સરકારી યોજના , સરકારી ભરતી અને લેટેસ્ટ ન્યૂઝ માટે અમારા વોટ્સઅપ નંબર +91 9723795769 ને તમારા વોટ્સએપ ગ્રુપ માં એડ કરો

Joine whatsApp group

Search This Website

Thursday, 20 May 2021

Natural Ways to Improve Oxygen

Natural Ways to Improve Oxygen 

Natural Ways to Improve Oxygen LevelRemdesivir (Veklury) was the first drug approved by the FDA for treating the SARS-CoV-2 virus. It is indicated for treatment of COVID-19 disease in hospitalized adults and children aged 12 years and older who weigh at least 40 kg.



 The broad-spectrum antiviral is a nucleotide analog prodrug. Full approval was preceded by the US FDA issuing an EUA (emergency use authorization) on May 1, 2020 to allow prescribing remdesivir for severe COVID-19 (confirmed or suspected) in hospitalized adults and children. Upon approval of remdesivir in adults and adolescents,
















How is blood oxygen level measured?
The most efficient way to monitor blood oxygen levels is by an arterial blood gas or ABG test. For this test, a blood sample is taken from an artery, usually in the wrist. This procedure is very accurate, but it can be a little painful.





An ABG test can be difficult to do at home, so a person may wish to do an alternative test, using a small device known as a pulse oximeter.


A pulse oximeter is a small clip that is often put on a finger, although it can also be used on the ear or toe. It measures blood oxygen indirectly by light absorption through a person’s pulse.


Although the pulse oximeter test is easier, quicker, and not painful, it is not as accurate as the ABG test. This is because it can be influenced by factors such as dirty fingers, bright lights, nail polish, and poor circulation to the extremities.





Low blood oxygen levels can result in abnormal circulation and cause the following symptoms:

shortness of breath
headache
restlessness
dizziness
rapid breathing
chest pain
confusion
high blood pressure
lack of coordination
visual disorders
sense of euphoria
rapid heartbeat
Causes





Hypoxemia, or oxygen levels below the normal values, may be caused by:


not enough oxygen in the air
inability of the lungs to inhale and send oxygen to all cells and tissues
inability of the bloodstream to circulate to the lungs, collect oxygen, and transport it around the body




Why is this medication prescribed?

Remdesivir injection is used to treat coronavirus disease 2019 (COVID-19 infection) caused by the SARS-CoV-2 virus in hospitalized adults and children 12 years of age and older who weigh at least 88 pounds (40 kg). Remdesivir is in a class of medications called antivirals. It works by stopping the virus from spreading in the body.


Remdesivir injection may cause serious reactions during and after the infusion of the medication. A doctor or nurse will monitor you carefully while you are receiving the medication. Tell your doctor or nurse immediately if you experience any of the following symptoms during or after the infusion: chills or shivering; nausea; vomiting; sweating; dizziness upon standing up; rash; wheezing or shortness of breath; abnormally fast or slow heartbeat; or swelling of the face, throat, tongue, lips, or eyes. Your doctor may need to slow down your infusion or stop your treatment if you experience these side effects.




the EUA was updated to maintain the ability for prescribers to treat pediatric patients weighing 3.5 kg to less than 40 kg or children younger than 12 years who weigh at least 3.5 kg




Remdesivir (Veklury) was the first drug approved by the FDA for treating the SARS-CoV-2 virus. It is indicated for treatment of COVID-19 disease in hospitalized adults and children aged 12 years and older who weigh at least 40 kg. The broad-spectrum antiviral is a nucleotide analog prodrug. Full approval was preceded by the US FDA issuing an EUA (emergency use authorization) on May 1, 2020 to allow prescribing remdesivir for severe COVID-19 (confirmed or suspected) in hospitalized adults and children. Upon approval of remdesivir in adults and adolescents,



the EUA was updated to maintain the ability for prescribers to treat pediatric patients weighing 3.5 kg to less than 40 kg or children younger than 12 years who weigh at least 3.5 kg





Remdesivir is an investigational drug being studied to treat coronavirus infection, also known as COVID-19. It has not been approved by the FDA for general use. However, the FDA is now allowing remdesivir to be used in human studies and for emergency use in certain hospitalized patients. More information should be provided by the doctor from either the Informed Consent form for a study or the FDA Fact Sheet for Patients and Parents/Caregivers for emergency use.There is limited information known about the safety and effectiveness of using remdesivir to treat COVID-19. Some study results show that remdesivir may help some patients get better sooner. The information in this document reflects preliminary and emerging data, which is evolving and subject to reassessment. Users should be aware of these considerations in their review of investigational drug data, and it is always the responsibility of treating practitioners to exercise independent judgment in making care decisions.

No comments:

Post a Comment